Skip to main content

Day: July 23, 2020

Half-year summary of the liquidity contract as of June 30, 2020

PARIS, FRANCE, July 23, 2020 – Half-year summary of the liquidity contract as of June 30, 2020Pursuant to the liquidity contract granted by the Company to EXANE BNP Paribas, as of June 30, 2020 trade date, the following elements appeared in the liquidity account:97,226  Tarkett shares€ 843,207During the 1st half-year 2020 contract summary, it traded a total of: Purchase : 369,226   shares, for an amount of € 4,321,586   (1,505  transactions)Sale : 340,179 shares, for an amount of € 4,072,610  (1,675   transactions)As a reminder, as of December 31, 2019, date of the beginning of the interventions, the following elements appeared in the liquidity account:€ 1,129,524### Investor Relations ContactTarkett – Emilie Megel – emilie.megel@tarkett.comMedia contactsTarkett – Véronique Bouchard Bienaymé – communication@tarkett.comBrunswick...

Continue reading

Bilan semestriel du contrat de liquidité au 30 juin 2020

PARIS, le 23 juillet 2020 Au titre du contrat de liquidité confié par la Société à Exane BNP Paribas, en date de dénouement du 30 juin 2020, les moyens suivants figuraient au compte de liquidité :97 226 titres Tarkett843 207 €Au cours du 1er semestre 2020, il a été négocié un total de :à l’achat, 369 226  titres, pour un montant de 4 321 586  € (1 505  transactions)à la vente, 340 179 titres, pour un montant de 4 072 610 € (1 675  transactions)Il est rappelé qu’au 31 décembre 2019, date du début des interventions, les moyens suivants figuraient sur le compte de liquidité :1 129 524 €Contact Relations InvestisseursTarkett – Emilie Megel – emilie.megel@tarkett.comContacts MediaTarkett – Véronique Bouchard Bienaymé – communication@tarkett.comBrunswick – tarkett@brunswickgroup.com – Tel.: +33 (0) 1 53 96 83 83A...

Continue reading

Quadient and Infosys Announce Global Partnership to Enhance Delivery of Customer Experience Management Solutions 

Quadient and Infosys Announce Global Partnership to Enhance Delivery of Customer Experience Management Solutions Paris, July 23, 2020Quadient (Euronext Paris: QDT), a leader in helping businesses create meaningful customer connections through digital and physical channels, announced today that Infosys (NSE: INFY), a global provider of next-generation digital services and consulting, has become a Platinum Business Partner in Quadient’s Partner Advantage Program.Infosys will leverage and supply Quadient solutions to provide businesses with the leading omni-channel Customer Communication Management (CCM) platform and the capability to meet complex communication needs, while being aligned to their customer experience strategy. Additionally, Infosys and Quadient will jointly develop innovative solutions in the customer experience management...

Continue reading

Quadient et Infosys annoncent un partenariat mondial pour renforcer la distribution de solutions de gestion de l’expérience client

Quadient et Infosys annoncent un partenariat mondial pour renforcer la distribution de solutions de gestion de l’expérience clientParis, le 23 juillet 2020Quadient (Euronext Paris : QDT), un leader des solutions d’entreprise visant à faire de chaque interaction client – via un canal physique ou digital – une expérience riche et personnalisée, a annoncé aujourd’hui qu’Infosys (NSE : INFY), acteur mondial spécialisé dans le conseil, la technologie, l’externalisation et les services de nouvelle génération, est désormais un Partenaire commercial Platinum dans le cadre du programme Partner Advantage de Quadient.Infosys intègrera et distribuera les solutions Quadient afin d’offrir aux entreprises la plateforme omnicanale de gestion de la communication client (CCM) la plus avancée en réponse aux besoins de communication...

Continue reading

Premier semestre 2020 : Poursuite de la croissance malgré la crise sanitaire et économique – Marge brute : 35,1 M€, en croissance proforma de +8,0%

Communiqué de PresseParis, 23 juillet 202017:40 CEST  Premier semestre 2020 :Poursuite de la croissance malgré la crise sanitaire et économiqueMarge brute : 35,1 M€, en croissance proforma1 de +8,0%Forte progression attendue des résultats sur l’exercice 2020 :Objectif de marge d’EBITDAr2 supérieure à 10%Artefact (FR0000079683 – ALATF – éligible PEA-PME) publie aujourd’hui sa marge brute du premier semestre 2020.Poursuite de la croissance en dépit de la crise provoquée par le COVID-19, une activité semestrielle en hausse de 8,0%Après un premier trimestre 2020 en croissance proforma de près de 17%, le Groupe affiche une marge brute à l’équilibre (-0,3%) au second trimestre à 16,7 M€. Le ralentissement de la croissance dès le premier trimestre dans les implantations asiatiques s’est naturellement intensifié une fois le confinement décrété...

Continue reading

XBiotech franchit une nouvelle étape dans la production de sa nouvelle thérapie révolutionnaire potentielle anti-IL-1⍺

AUSTIN, Texas (États-Unis), 23 juill. 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd’hui avoir franchi une étape cruciale dans le développement de sa prochaine génération d’anticorps True Human combattant les inflammations. La Société met actuellement au point un nouvel anticorps pour remplacer un anticorps True Human anti-IL-1⍺ de génération précédente, commercialisé en 2019 pour 750 millions de dollars au comptant et jusqu’à 600 millions de dollars en paiements échelonnés. Conformément aux termes de la vente, XBiotech a été autorisée à poursuivre la découverte de nouveaux anticorps True Human anti-IL-1⍺ utilisés dans tous les domaines de la médecine, à l’exception de la dermatologie.Les scientifiques de XBiotech ont découvert et caractérisé un panel de nouveaux anticorps anti-IL-1⍺...

Continue reading

XBiotech erreicht Meilenstein in der Produktion seiner neuen Anti-IL-1⍺-Therapie mit Blockbusterpotenzial

AUSTIN, Texas, July 23, 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) hat heute bekanntgegeben, dass das Unternehmen einen entscheidenden Meilenstein bei der Entwicklung seiner entzündungshemmenden True Human-Antikörper der nächsten Generation erreicht hat. Das Unternehmen entwickelt einen neuen Antikörper, der die True Human Anti-IL-1⍺-Antikörper der Vorgängergeneration ersetzen soll, die 2019 für 750 Millionen US-Dollar und bis zu 600 Millionen US-Dollar in Meilensteinzahlungen verkauft wurden. Im Rahmen des Verkaufs wurde es XBiotech erlaubt, neue True Human Anti-IL-1⍺-Antikörper zur Verwendung in allen medizinischen Bereichen mit Ausnahme der Dermatologie zu erforschen.Anfang dieses Jahres haben Wissenschaftler von XBiotech erstmals ein Panel der neuen Anti-IL-1⍺-Antikörper eines menschlichen Spenders untersucht und charakterisiert....

Continue reading

Cole, Scott & Kissane Standardizes on Zoom to Conduct First Virtual Trial by Jury in Florida

SAN JOSE, Calif., July 23, 2020 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announces that Cole, Scott & Kissane (CSK), the largest law firm in Florida with more than 500 attorneys in 13 offices, has standardized on Zoom’s video-first unified communications platform. CSK attributes its ability to weather the COVID-19 pandemic without layoffs or pay cuts to its use of Zoom.Since March, CSK has used Zoom daily to conduct legal proceedings including depositions, hearings, and mediations. In April, the firm participated in the very first Zoom oral argument in Florida, hosted by the Fourth District Court of Appeal (DCA). Subsequently, CSK also participated in oral arguments in Florida’s Third DCA and First DCA. Last week, on July 13, CSK became the first law firm in Florida to do a virtual trial by jury....

Continue reading

H&E Equipment Services Announces 2020 Second Quarter Earnings and Conference Call Date

BATON ROUGE, La., July 23, 2020 (GLOBE NEWSWIRE) — H&E Equipment Services, Inc. (NASDAQ: HEES) today announced that it will release its 2020 second quarter financial results before the market on Tuesday, August 4, 2020.  The Company will also hold a conference call to discuss second quarter results on Tuesday, August 4, 2020, at 10:00 a.m. (Eastern Time).  To listen to the call, participants should dial 877-270-2148 approximately 10 minutes prior to the start of the call.  A telephonic replay will become available after 1:00 p.m. (Eastern Time) on August 4, 2020, and will continue through August 11, 2020, by dialing 877-344-7529 and entering the confirmation code 10146660.The live broadcast of H&E Equipment Services’ quarterly conference call will be available online at www.he-equipment.com on August 4, 2020, beginning at...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.